PregPred: an In-Silico Alternative to Animal Testing for Predicting Developmental Toxicity Potential
Abstract
Background: Understanding potential prenatal and development toxicity hazard associated with the use of pharmaceutical and cosmetic products is an important component of women health. This hazard can be estimated from chemical structure of respective agents using Quantitative Structure-Activity Relationship (QSAR) models; however, the development of reliable models is challenging due to the complex nature of this endpoint. Methods: Aggregating and curating data from the Food and Drug Administration (FDA), Teratogen Information System (TERIS) database, and select independent studies, we have created, to the best of our knowledge, the largest publicly available dataset comprising compounds annotated as developmental toxicants or not toxicants. Results: We built several binary classification QSAR models exhibiting a correct classification rate of 62-72%, a sensitivity of 66-75%, a specificity of 59-82%, and high coverage of 70-90% assessed using five-fold external validation protocol. We developed a publicly accessible web portal PregPred for developmental toxicity prediction of both overall toxicity and trimester-specific toxicity predictions. Conclusions: Due to high accuracy and coverage as well as public accessibility of the respective web portal, our models can be employed as a computational tool to support regulatory assessment of pharmaceutical and cosmetic products in alignment with the 3Rs (refining, reducing, and replacing) of animal testing. This in silico model…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.